NCT06243224Completed
The Effect Of High Intensity Interval Training And Moderate Intensity Continuous Training In Patients With Hypertension
The Effect Of High Intensity Interval Training And Moderate Intensity Continuous Training On Cardiopulmonary Parameters And Clinical Findings In Patients With Hypertension:A Randomized Comparative Study
Source: ClinicalTrials.gov · Last updated 13 May 2024
Brief summary (registry, in English)
Comparison of high intensity interval training (HIIT) and moderate intensity continuous training (MICT) in patients with hypertension patient in terms of aerobic capacity, blood pressure level, anxiety and depression scores, quality of life, kinesiophobia levels and sleep quality measurement.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 38 (actual)
- First submitted
- 13 Jan 2024
- Start date
- 15 Apr 2023
- Primary completion date
- 15 Feb 2024
- Lead sponsor
- Ankara City Hospital Bilkent
- Diseases
- High blood pressure
- NCT number
- NCT06243224
What you commit to
- Study type: Interventional
- Participants enrolled: 38
- From 15 Apr 2023 to the primary completion date, 15 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Clinical heart failure
- Uncontrolled hypertension
- Secondary hypertension
- Moderate or severe pulmoner disease
- Symptomatic peripheral arterial disease
- Unstable arrhythmia
- Unstable or severe angina
- Moderate or severe valvular heart disease
- Congenital heart disease
- Recent history of stroke
- Diabetes mellitus
- Severe musculoskeletal disease causing exercise limitation
Other
- Cognitive limitation unable to understand the research protocol
- Pace maker presence
- Language problem
- Autonomic neuropathy
- Cardiomyopathy
- Being unable to continue treatment (3 days a week for 4 weeks)
Who the study is looking for
- Being diagnosed with Isolated Hypertension
- Being cognitively competent
- Being between the ages of 35-55
- Having given informed consent to participate in the study.
Age in the registry: 35 years to 55 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ankara Bilkent City Hospital Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.